I don't think you can conclude that from one patient, that's not how medicine works. Whether to actively surveil vs treat depends on individual patient charact

I don't think you can conclude that from one patient, that's not how medicine works. Whether to actively surveil vs treat depends on individual patient characteristics and grade (generally Gleason 7+) and the fact that you didn't have a complication does not mean they're not sufficiently high. On a population level analysis the evidence clearly support that there is no improved mortality with prostate cancer screening.